AuthorRohit Chauhan

Stock analysis : FDC ltd

S

About
FDC is an Indian Pharmaceuticals company with an operating history of more than 50 years. The company is into formulations, synthetics, nutraceuticals and bio-tech with a focus on therapeutic groups of ORS, opthalmologicals, dermatologicals, Anti-biotics, Cardio and diabetes. The company has several well known brands such as electral, enerzal etc.

Financials
The company has maintained an ROE in excess of 20% for the last 10 years. In addition the company is conservatively financed with zero debt and excess cash position during the same period.

The company has maintained fixed asset turns (sales/ fixed asset) at the same levels by investing in fixed assets in line with the topline growth. The working capital turns (sales/ working capital) have improved from around 5 to 9+ levels in the last 10 years. This improvement has been driven mainly by an improvement in receivable turns (sales/ account receivables).

The net margins have improved from the 15% levels to 20% levels mainly due to drop in raw material prices.

Positives
The company has maintained a high ROE with a very conservative balance sheet. The company has maintained excess cash and financed growth with the free cash flow generated from operations.

The company has also been able to maintain a topline and bottom-line growth in excess of 15% in spite of high competition and change in the operating environment (changes in patent laws in 2005).The company announced a buy-back in 2008 and has been able to use the excess cash to reduce the number of outstanding shares.

The company has a consistent track record of introducing several new products every year and currently spends almost 3% of sales on R&D which is a crucial investment in the pharma business.
The company is conservative in other aspects of the business such as foreign acquisitions (none) or expanding in the foreign markets (exports are 10% of total turnover).

Risks
The company operates in a business characterized by a high level of competition from domestic and deep pocketed global pharma companies. Although company spends a substantial amount on R&D, global players such as JNJ spend in excess of 10% on R&D. As a result the R&D spend of the company is small by most standards and can be utilized only to develop the off patent molecules in the form of generics for the local and export market.

This is a very competitive business with low to moderate profitability and several other domestic pharma companies such as a CIPLA or Dr reddy’s have a major head start in the space (they are almost 10 times the size of FDC)

In addition the company is also into the consumer health space which is closer to FMCG than pharma products and requires a different set of skills and focus.

Competitive analysis
The industry is characterized by a large number of domestic and foreign competitors. India, China and other BRIC countries are the major growth areas now and all the major companies are now targeting India for growth. The market is already experiencing a high level of competition and activity. One indicator is the number of new product launches and corresponding marketing and sales cost.

The generics opportunity in the export markets of US, Europe and Japan is big with thin margins and high levels of competition.

In case of a drug coming off patent, the pricing typically drops off by more than 60% in the first year and by almost 80% by the third year of patent expiration. As a result these are high risk – high return, limited duration type of opportunities.

Management quality checklist

– Management compensation – Management compensation seems reasonable at less than 3% of net profit.
– Capital allocation record – Fairly good till date. The management has kept the ROE high, inspite of high cash levels. In addition the management has also used the excess capital to buy-back shares which is a sensible decision.
– Shareholder communication – Very sketchy. The mandatory disclosure in terms of the balance sheet, P&L and other schedules are as per the standards. However the company, like other mid cap companies, is very sketchy and does not provide enough discussion on the subjective parts of the business. It gives a very generic overview of the business and has not discussed the plans for the future in detail. If you compare with the annual reports of other pharma companies like Dr reddy’s, the differences are glaring. I can live without too much detail for a steel or a cement company as the numbers give a good picture, but for a pharma or IT company the subjective details are important to evaluate the future of the company. This is a big negative for me.
– Accounting practice – Seems ok. Nothing out of the ordinary
– Conflict of interest – Related party transactions seem fine. I could not find anything out of the ordinary.

Competitor analysis (top 2-3 competitors)
The main competitors for FDC are the domestic pharma companies such as Dr reddy’s, Cipla, Sun pharma and Ranbaxy. These companies are much larger than FDC and are not strictly comparable. At the same time, competition in the pharma industry is by segment. The term pharma is too broad for comparison. If one has to compare competitors, it would be by therapeutic groups such as anti-bioitics, cardio-vasculars, opthalmologicals etc.

FDC has a leading position in some segments such ORS and a few leading brands such as ZIPANT-D SR, 1-AL etc.

The net margins for FDC are comparable to the other top companies and the ROE is also in the same range of 20%+. The overall business risk to FDC is much lesser as the company has not expanded aggressively in the foreign markets. Conversely the returns and growth have been lower too compared to the other aggressive competitors such as Dr reddys, SUN pharma etc.

Valuation
A DCF calculation with a net margins of around 16-18% and 10-12% growth (both assumptions are conservative based on past history), gives a fair value of 120-140 per share. The company would be a good value below a price of 70 per share or if the company started doing far better than the assumptions in the above valuation.

Conclusion
FDC has been a conservatively managed company which has done fairly well in the past 10 years. The company has expanded mainly in the domestic markets and is now expanding slowly into exports via new ANDA filings. The company is likely to maintain a 10-15% growth in line with the market growth with some additional growth coming from exports.

As an investor, I would expect the company to give me moderate returns at low risk. I don’t think the company can be a multi-bagger in the short to medium term.

Disclosure : I have position in the stock. The above analysis is not to recommend the stock. So please do your own homework on it.

Quarterly result review – Some standouts

Q

The quarterly result for most companies are out and I have been reviewing the results of the companies in my portfolio. In most of the cases the results were as expected, but in some cases there have been some unexpected changes – in some cases good and a few not so good.

Cheviot Company – Now this is a company most of you would wonder, why the hell even invest in it? Cheviot is in the business of jute manufacturing and is located in West Bengal. I have written about company here and continue to hold a small position. This company operates in an unattractive industry in a business unfriendly state. The company workers go on a strike every alternate year and the compensation costs are now in excess of 15%.

If the above is not enough, the export market of the company has stagnated in the last few years due to the recession. So why hold this stock?

The company sells for less than cash on books, has been able to earn more than 15% on invested capital and pays out a fair dividend. The company is now focusing on the local market and has started growing again. However, all said and done, it is not the best of my picks although I have not lost money on it and I will exit in due course now.

Facor alloys – I wrote about this company recently here. The current quarter numbers are very good. If one excludes the one time power related charges, the company has earned almost 14 Crs in the quarter which is almost equal to the entire profit of the previous year.
This is a very cyclical business and one should not extrapolate the quarter numbers. However I think the company should do fine over a business cycle and is still selling cheap.

Lakshmi machine works – The company came out with decent numbers as expected. The key news on the company is that company has initiated a buyback which is good way of utilizing capital. I think the company could have done this earlier when the stock was cheaper, but it is quite likely that the management was conserving cash during the recession.

Gujarat gas – I have discussed the company here. The company came out with good topline and bottom line numbers(20% growth) The company continues to do well and is a well managed company. I personally think that once the company ties up more long term supply sources, it should be able to do even better and think that the fair value will keep increasing at a good rate.

The tech companies (Infosys, NIIT tech etc) – Infosys has come out with average numbers (10% sales growth, profit de-growth) in terms of growth. The company continues to generate a high return on capital, but the growth is now muted due varying factors such as recession in the US, exchange rates and rising costs in India. The valuations are still much higher and assume higher growth in the future. That may very well happen, though I am not betting my money on it – I have reduced my holding by a substantial amount already.

NIIT tech has had miserable performance in the last few years ( have written here about the company). The topline growth was non-existent and the silly foreign currency hedges kept biting the company. Those hedges are now being worked out and hopefully the management would not repeat the same mistake (of putting a multi-year currency hedge). The company has had a good topline and bottom line growth due to increased business in India (some of it is one time). I think the company should continue to give high single digit growth in the next few years.

The stock is not undervalued by a large margin and as a result I have reduced my position substantially.

The quarterly circus
Quarterly earnings are a big drama in the US. It is almost a ritual and every time a company misses its quarterly estimates, the stock gets punished severely. In India, the market was immune from this disease, that is till now. I have been noticing that in the last few quarters, any small slowdown or drop in growth is being punished severely and conversely, upside surprises are being rewarded.

A lot of participants may attribute this to higher efficiency and greater volumes etc. This may very well work for traders and in some cases for long time investors too. However I think it is bad for the companies and investors as a whole. A focus on quarterly numbers can cause management to take short sighted decisions which ends up destroying than creating value for the shareholders (remember Enron ?).

The focus of market on short term earnings may be or may be a good thing from varying points of view, but it is here to stay. In such a scenario, it can work for a long term shareholder if you can look past the temporary disappointment and buy the beaten up stock where the company will continue to do well in the future.

Truncated analysis: Shakti Met dor

T

About
Shakti Met Dor is a leading manufacturer of steel doors since 1995. The company was established primarily to manufacture steel doors, windows, and other building material products to cater to the construction industry. Shakti has expanded its facility to 180,000 Sq.ft of manufacturing and warehouse space capable of producing 300,000 doors and frames. Shakti has seven sales and marketing branches across the major metropolitan cities in India.

Financials
The company is in a niche business and has done fairly well in the last 8-10 years. The ROE has been maintained in excess of 20% with the recent drop due to new CAPEX and higher receivables. The Debt levels have gone up due to the new capacity and due to high additions to accounts receivables in the current year.

The inventory turns has remained at around 10 turns per year and the working capital turns in range of 3.5-4 which seems the reasonable. The total asset turns are at 2.3 which is likely to improve to around 3 with the capex being completed in the last one year.
The one key area of concern is the increase in accounts receivables which is now at around 150 days. I think this needs to be watched closely over the next few years.

Positives
The company operates in a profitable niche and has been able to scale up well in the last few years. The company has been able to deliver a topline growth in excess 20% in the last 10 years and bottom line growth (inspite of the recent drop) in roughly the same range.

The company has recently completed its capex cycle and with the growth in the construction, IT and other user industries, should be able to grow well. In addition the profit margins are likely to improve in the next few years, if the company is able to reduce the debt load and control the raw material costs. The improvement is not a given, but based on the past performance likely to happen.

Risks
There are several key risks in the business. The number one risk is the delisting plan of the company (see here). The management plans to delist the company and has offered around 195/ share. The management holds 56% of the company and needs 34% more to delist. Around 100 shareholders (including the promoters) hold around 90% of the company. I do not have details of these shareholders, but if the management has an informal agreement with them, then the delisting may happen at the proposed price. The minority shareholders holding 10% of the stock will not matter much in the reverse book building process.

A consent order was passed by SEBI on non-compliance of the company of the Substantial Acquisition of Shares and Takeovers Regulations in June 2010. It seems the promoters were acquiring the shares from the market since 1998 and have not disclosed it. This information is missing from the annual reports till 2008-2009. I think this does not inspire confidence

The other risk is the increase in the accounts receivables. This may not be as much as risk as the last quarter of 2010 has seen a sudden increase in topline and hence the year end numbers could be inflated due to that. However one has to watch this number closely as the debt more than 6 months doubled in 2009 and the total debt has increased further in 2010. This increases the risk of bad debt write-offs in the future.

Management quality checklist
– Management compensation: On the higher side. Management compensation is around 12% of net profit
– Capital allocation record: Has been sensible and good till date.
– Shareholder communication – Not good. The management has not been transparent in their communication (see the point on risks above)
– Accounting practice – Seems fine for most part with all the mandatory disclosures in the latest AR.
– Conflict of interest – None in the notes to account. However see the risks section for such incidents.
– Performance track record – Good from a business performance perspective. Corporate governance standards have not been satisfactory.

Conclusion
I started this analysis a few days back and was impressed with the fundamentals. On looking through the BSE filing, I noticed the delisting notice from the company and was thinking of this as an arbitrage or long term opportunity. However the nature of the shareholding (thanks to ninad for pointing that out), I have concerns on how the delisting will work out for the minority shareholder. In addition, some of the past actions do not inspire confidence.

As I discussed in the last post, my valuation template has a checklist which I go through before doing a more detailed analysis on the company. On running through the checklist, I have come across the risks mentioned earlier in this post. I am not too comfortable with those risks and hence inspite of good fundamentals have decided to drop this idea.

Note: If you hold the stock and don’t think the above issues are material enough, it may be so. However I am more conservative and don’t want to put my money on the line to test it out.

Analysis – Mayur uniquoters

A

About
Mayur uniquoters is in the business of manufacturing synthetic leather. The company’s products find usage in the footwear, automotive, apparel and sports goods industry.
The company supplies to the major automotive companies in the country and abroad. The company has Ford, GM, and Chrysler as customers in the export market and maruti, Tata motors, Hero Honda and other local players as domestic customers. In addition the company is also a supplier to the replacement market.

Financials
The company has performed quite well in the last 8-10 years. The topline has grown by 20% and net profits by 25% in the last 8 years. The current year profits are a cyclically high due to lower raw material costs and exchange related gains.
The company has consistently maintained an ROE of 15%+ and has reduced its debt to 0. The company now has excess of cash of almost 15 crs on its balance sheet.
The current net margins of the company are around 9% which as stated earlier are higher than normal. The normalized profit margins can be assumed to be between 6-7%.

Positives
The company has been doing fairly well in the last few years. The company has been expanding in the export markets and is now an approved supplier to several international OEMs such ford, GM etc. The company has managed to grow inspite of the recession in the export markets.
The company is also a debt free company and can fund the required capex from the cash on the books.

Risks
The company as an OEM supplier is bound to face continued and relentless price pressure from its customers. In addition, the raw material component is around 75% of the sale price and hence the margins of the company are very sensitive to the raw material prices.

The industry is very competitive and it is unlikely that any participant in the industry can earn large profits in the long run. A ROC (return on capital) of 15% would be a good return for an efficiently managed company.

The no.1 risk is not the business, but the management’s intentions. The management awarded themselves around 800000 (around 15% of equity) warrants in 2007-2008 and exercised those warrants at market price. I consider this as a big negative.
As I have stated in the past – warrants are not free and have a value in itself. In addition, the company did not seem to be in need of capital at that time. The sole purpose of issuing the warrants seemed to be to increase the holding of the promoters (which now stands at almost 75%)

Competitive analysis
The product is characterized by minimal brand value for the end customer. The customers (automotives, apparels etc) however value quality and a reliable supplier for the synthetic leather going into their own products. As a result the brand value exists in the mind of the OEM (original equipment manufacturer) buyer.

The industry is characterized by a large number of smaller players in the unorganized sector of the market. The industry is highly competitive with thin margins and poor quality among the smaller players.

The larger companies like Mayur have an opportunity to establish themselves as reliable suppliers to the OEMs and benefit from the economies of scale at the same time.

Management quality checklist
– Management compensation: the management compensation does not appear to be high. The management (who are also the promoters) is paid around 5% of the net profits (around 80 lacs) which although not low, is reasonable.
– Capital allocation record: the capital allocation record seems to be decent. The management has paid down debt, raised dividend over time and now has cash to re-invest in the business. It will be interesting to see how the management will deploy the surplus cash in the future.
– Shareholder communication: disclosure seems to be adequate and in line with other companies.
– Accounting practice: could not see anything out of the ordinary. I need to dig deeper to find if there is anything to be concerned about
– Conflict of interest: other than the warrants, I could not see any related party transactions of concern.
– Performance track record: fairly good so far

Valuation
The company can be assumed to have a normalized profit margin of around 6-7%. As a result the net profit is in the range of 12-13 crs on a normalized basis. As the industry is highly competitive, it is difficult to assume an extended period of high returns for the DCF calculation.
A back of envelope calculation (assuming PE of 12-13) gives a fair value of 150 crs.

Conclusion
The current price is 50% of the fair value. The crucial point is not at arriving at a fair value number, but figuring out the economics and future profitability of the business. If the current numbers can be maintained, then the stock is a bargain.
The other major concern I have is the management attitude towards the minority shareholders. The warrant issue does not inspire confidence and has left a concern in my mind.
I am still halfway through my analysis and will make up my mind after I dig deeper into the company

Disclosure: I have a starter position in the company. A gain on my current position will not pay for than a nice dinner. Please make your investment decisions independently.

Keeping papers in order

K

This is going to be a fairly odd and short post. I am going to discuss a topic which is not a fun topic, but nonetheless important.

Are your papers in order?
God forbid, if something were to happen to you tomorrow – does your family know the financial situation and has access to all the documentation?

I have heard of a lot of stories and personally encountered some, where the head of the family died and the heirs realized that the paperwork was a mess. I cannot tell you how painful it is to sort such matters.

So, I would suggest each one on us should atleast do the following
· Make a will
· Please add nominee in all your accounts – bank accounts, demats, FD etc
· Have a term insurance which pays in the unfortunate event of your death
· List all your accounts details on a piece of paper, make two copies with one in possession of a close family member and the other one in a locker
· Consolidate your provident fund with your current company – I repeat, please do this now! Getting provident fund issues sorted is a nightmare especially if they are old issues.
· File all the paperwork properly and update it atleast once a year.

I am myself partly guilty on not following all of the above. However I am continuously trying to ensure that my paperwork is in order and plan to clean it up further in the next 1-2 years.

You may be the next warren buffett or Rakesh jhunjhunwala or whatever you are dreaming of, but if your paper work is a mess, your family is going to suffer. The last thing you want is for your family to suffer due to the paperwork in addition to the emotional problems.

A personal experiment

A

I was recently talking to a friend and he made an interesting comment after looking at my blog.

‘Why do you target beating the market by 2-5%, when you can make 80-90% per annum by trading? I recently started trading and have been making almost 7-8% per month. You should do that too!’

I have heard this comment from a lot of people in the past. The only common feature is that such people trade for a few months, make good returns and extrapolate it to annual returns. Ofcourse, the very same people after losing money in the market make a hasty retreat and are never heard of again.

The quants
I am currently reading a book – The quants. It is quite an entertaining book, though I doubt there is anything to learn from it. The book is about various kinds of traders who use mathematical models and high power computers to trade in the market. It talks about a few hyper successful traders at various firms such Goldman sachs, Morgan Stanley, deutsche bank and hedge funds such as renaissance technologies and citadel investment group.

Some of these trader/ investors were pioneers in their fields, the best of the best and achieved in excess of 30% annual returns over 10 years or more. The best returns were posted by renaissance technologies, which seems to have posted annual returns of around 40% over 2 decades.

The point of the above commentary is this – If you can make 30-40% annual returns for a few years and prove it, there are people who will be ready to handover millions to you to manage. You will be rich and can retire soon. If you can make 40% or more, then you will be considered a god and there is will be books written about you – think of George soros and others.

If you think you can make 70-80% per annum for the next 10 years, then you are day dreaming. If you think you can make these kinds of returns, as my friend suggested while working in a full time job, you should meet a psychiatrist and get a mental health check done.

I think the chance of 1 crore rupees dropping on someone from the sky while walking on the road is higher than making 70-80% per annum for the next 10 years. A 75% return for ten years will give you 269 times you starting capital and 73000 times your capital in 20 years.

A personal experiment
Let me come back to title of my post. If you are new to the blog, let me say it outright – I am biased against short term trading. I do not believe it is the right approach for me. It may work for others, but not for me.

I have said this more out of a general belief and not based on any specific experience, atleast till now.

So, this time around I tried an experiment. I decided to experiment with trading in the last few months. I bought some stocks for day trading, did some momentum buys and sell and did some news based trading too.

At the end of the experiment, I tabulated my results and found that I had made around 18% on my capital in around 3 months. The maximum loss was around 6% and the highest gain on a single position was 11%. The average holding period ranged from 2-3 days to around 15 days.

A success?
If I annualize, then the returns come to around 72%. Should I declare it a success and start trading actively?

I do not term the experience as a success and do not plan to trade ever again. Let me tell you why.

I typically check my long term positions once in a month or a quarter. My broker is one unhappy guy as I have very few orders in a month and my account is generally a sleepy account.

The above experiment seems to be a success only in terms of the returns. What is not obvious is the effort and the pain behind it. I found myself scouring the internet and bse website for news and tips. In addition, I found myself checking the stock price several times in a day. There was definite change in my thought process as I found myself more anxious, stressed and reacting more and more to daily news.

I realized that my short term approach started infecting my long term though process too. I started looking at my long term holding frequently and started getting more anxious about them. One fine morning, I just plugged the plug and stopped all the trading. Life is good now and back to normal 🙂

A typical experience?
So does it mean long term investors should not trade? No, it only means that I should not trade because I do not have the temperament to do it.

The point of the post it this – One should invest based on one’s own temperament. Some people like fast paced action and the adrenaline rush, so trading may the right approach for them. I prefer a slower and more sedate approach where I will analyze a company for a long time and then slowly build my position. Now if that nets me lower returns, then so be it! Atleast I will sleep well at night and not check stock prices continuously during the day.

Quick analysis – Patels airtemp

Q

About
Patels airtemp is in the business of condensers, heat exchangers and air conditioners. The company is in the same industry and business space as Blue star limited which is a better known company. You can find more about the company
here

Financials
The company has been business since 1973, but has started doing well for the last 5 years. The ROE of the company has increased from 7% to around 30% in 2009. The company is almost debt free and may have some excess cash by the end of 2010.

The company had a revenue of 72 Crs and 8.7 cr net profit in 2010.

Positives
The company has grown its topline by more than 30% and bottom line 40%+ in the last 6 years. However at the same time the growth has come from extremely small base. The company has paid off its debt and is now debt free.

The company has a fairly diverse clientele and supplies its products to a wide variety of industries such as cement, chemicals, petrochemicals, textiles and engineering. In addition the company has the benefit of an ever expanding and growing market for its products.

Risks
The company is in a very competitive business with competitive advantages related to scale of operations. A substantial portion of the business comes from projects which involves competitive bidding. The company has started growing in the last few years and it remains to be seen if the company will scale up and enter the big leagues.

The current margins are in the range of 10%+. Blue star which is in a similar business has margins in the range of 5-7%. The ROE for both the companies is in the same range as Blue star is a more efficient user of capital compared to Patels airtemp. The efficiency is mainly to the size of the company. The difference in margins could be due to the pricing/ quoting approach of the companies.

If blue star is more aggressive in bidding, then we are likely to see Patels airtemp follow the same path if it intends to grow beyond the current size. If this happens, we are likely to see a reduction in net margins, though the bottom line could still grow with the topline.
Bold
Conclusion
One can look at the financials of the company and assume that patels airtemp would continue to grow at the same rate. If one can make an assumption or have a strong reason to believe that the performance of the last 4-5 years will be repeated then the company is a bargain.

At the same time, one should also consider the fact that the company has been in the biz since 1973 and managed to grow to just 16 crs in the first 30 yrs. The rapid growth and improvement in the performance has come in the last 6 years.

I personally have not been able to make up mind on which scenario will play out and plan to follow the company and dig deeper. It is easy to assume that the company will repeat the performance of the last 6 years, declare the company to be undervalued and buy into it. I however would prefer to investigate deeper and watch the company for a while before buying into it.

Cooling your enthusiasm

C

The previous post had some questions on how to handle over-optimism on a stock, especially when one is analyzing it for the first time.

I think it is human nature to be over-optimistic during bull markets and pessimistic during the bear phase. Even if you think you are immune to it, I personally think there is some impact of the surrounding environment. I have seen in my case that my fair value estimates are on the lower side when the market is dropping (being too conservative) and on the higher side when the markets are shooting up.

The first step in managing this situation is to acknowledge that you are not different from others and could be getting impacted in the same manner. If you don’t acknowledge the problem, then there is nothing to resolve.

I typically remind myself of these points when faced with rapidly rising or crashing markets

Cannot predict markets
I cannot predict the markets. Period! I cannot divine the future and care two hoots if others can or cannot. If that is the case, then my decisions are based on what I know as of today and not what may or may not happen. As a result, I have lesser tendency to beat myself up for a decision at a later date.

The next logical point is that the future may prove me right or wrong. However if I make rational and intelligent decisions, luck evens out and I should do fairly well. Till date, I have seen that happen.

I try to note down my thoughts and reasoning when buying or selling a stock. This helps me in checking back on my thought process at a later date.

Cooling period
I have also accepted the fact that I am like everyone else – nothing special. So I will be swept by emotions from time to time. The best antidote to it is to have a cooling period when making a decision on a stock.

I start analyzing a stock and if I get too excited, I will create a small position to temper the urge or itch. I leave the analysis for a few days or weeks and will then come back to it with a fresh mind. A lot of times I have been surprised with my decision (what was I thinking!). The downside is that during a bull market, such an idea can run away from you. I think that’s an acceptable risk.

Search for negative opinion
I try to force myself to look for negative information which goes against my thesis. This helps in countering the optimisim and hopefully improves the analysis.
There are no magic bullets or set formulae in managing emotions. It comes down to our individual makeup and what works for us.

Watch list of stocks
I am analyzing the following stocks these days
Noida toll bridge
Facor alloys
HDFC bank
Patel airtemp

And a few others. The idea of analyzing these stocks is to understand the business and calculate their fair value. I have been building a list of ideas with my estimates of fair value. Most, or almost all the stocks are not in my buy range. However it is important to analyze these stocks in advance, so that when the opportunity comes, one can move fast and create a decent size position

Trusting your gut

T

One of the least discussed topics on investing is emotions. I have rarely found any discussion on this topic. Behavioral finance does take up this topic and there is a lot of academic analysis on the various pitfalls and mistakes of investors. However there is still a lack of discussion on emotions and how one should handle them while investing.

Are emotions important?

If you are Mr. Spock, then emotions do not matter. For the rest of us, emotions play a very important role in our lives and definitely in investing.

As an investor, one is faced with feelings of joy, confidence, euphoria or despair, frustration, fear and similar other emotions. I can’t speak for others, but I have had all these emotions and more.

Should feelings be ignored?
One school of thought is that one should be a completely rational investor and should take emotions completely out of investing. I find this as the stupidest advice.

Do you think that is possible? Can you invest without ‘feeling anything?

The only time one does not ‘feel’ anything is when one does not care about it. If you are dealing with your hard earned money, how will not feel anything?

Understand and manage feeling
I have found that it is far more important to acknowledge your feelings and then try to think rationally about them. In some instances, you may be able to realize that your feelings are leading you down the wrong path and you will be able to correct yourself. In other instances, your gut or feelings are telling you something and you are better off listening to them

My own experiences
During the start of my investing life, I rarely thought about how I felt and just went with the flow. For example, if I started analyzing a stock and ‘felt’ confident, then my tendency would be to rush through the analysis and just build a position.

Once I had created a position, a confirmation and consistency bias would set in and I would avoid negative information on the stock if it went against my view. If you think you and others are immune to it, think of the time you and your friends have tried to ‘defend’ your stock (as if your stock needs defending!) and have discounted someone who is giving you contrary information. This tendency sometimes gets vicious on public stock forums (which is one reason I avoid criticizing other’s stock picks)

The converse of the above situation occurred when the stock market was down and everyone was bearish. I found myself overly pessimistic like others and would constantly keep questioning myself. As a result I did not build as big a position as I should have – case in point: I bought concor in 2002-2003 at a PE of 5. I should have built a big position, but never did. Same with blue star and several others

My current approach
I did not get hit by lighting or have achieved any enlightenment like Gautama Buddha. I tend to feel the same emotions as earlier. The difference is that I try to acknowledge them when they happen and to understand what they are conveying.

During 2008, I too had feelings of uncertainty and some amount of doubt. However based on past experience and based on the valuations I could see, I decided to ignore them and went ahead with my positions.

Conversely, I have been feeling fairly smug and happy with my positions and optimistic (atleast till last month) in general. This matched with the feeling, others have about the market. I think this itself is a red flag for me. The time when I start feeling confident and on top of the world is the time to start getting worried. In response to this, I have started reducing my fully valued positions and have not really been buying much (though have been tempted several times).

I don’t go against my feelings always. On analyzing my past positions, I have realized that my position size is driven a lot by my feelings. I maintain a few major and some minor positions (see my portfolio here). I have found that the stocks in my minor holding are cheap and at a higher discount to fair value than major positions.

However for some reason which I cannot articulate, my ‘feel’ for the minor positions is not as good as the major ones. For example, I always felt that a grindwell Norton is a better position than a VST. As a result my position size has been larger in the former than the latter. On analyzing my past results I have found the major positions have done far better than the smaller positions (though I did not realize that at the time of making these investments).

I don’t claim to infallible. Far from it ! I have done enough silly things and confident that I will continue to do so (options may be one 🙂 ). However I think listening to your gut is important, even if you do not always follow it.

As an aside – I think if you feel a little bit apprehensive and scared when trying something new, it’s a good thing. It means that you are pushing the boundary of your learning. I feel the same with arbitrage and options and think that it is the right thing to do.

ABB buyback – An arbitrage opportunity ?

A

I recently received an email from pradeep about the ABB buyback offer (see deal announcement here). His question was – Does the buyback have an arbitrage opportunity? My response (With light editing to make it for better reading) is below

Dear Rohit,
How are you?

I wanted to know your opinion about ABB delisting. I have never done arbitrage but ABB has declared an open offer for 900 Rs and the shares, though jumped today to 830 Rs, still is at a 70 Rs discount to the offer price indicated by ABB.

I am not sure how one should think through this situation. I have invested some money today since the upside seems to be around 8% return in 2 months time. But I am wondering why the stock price did not end up at 880s level since the risk that ABB would withdraw the offer seems pretty low?

Is there any mistake in my thought process?
———————————————————————————————————–

Hi pradeep

Good to hear from you. Thanks for passing this info. I had a look at the offer and below are my thoughts
– The offer is not really a delisting offer. ABB – the parent, holds around 51% of ABB India. This open offer is to buy around 23% of the shares to take their shareholding to 75%. The purpose seems to be increase control.
– the acquirer has stated in the offer document that they do not intend to delist the company.

See this link here : http://www.bseindia.com/stockinfo/anncomp.aspx?scripcode=500002.

Deal Math
Let’s look at the deal math:

If you buy 100 shares, you pay around 83000. With public holding at 49%, the acceptance ratio will be 50-100% depending on the tender levels.

For acceptance ratio we can look at the shareholding structure. On the ABB site, you can see that around 30% is held by institution and the rest by individuals. 10% is held by LIC.

The key to acceptance ratio is how the institutions will tender. If they don’t, then you get 100% acceptance and a 10% upside

If the some of the institutions tender then you have a ratio between 50-80%. Let’s take 70% for assumption sake – then 70 shares get accepted and you make 63000. Let’s assume the rest – 30 shares you sell in market at pre-deal rate of 700-720. The total value comes to around 83000-84000. I am not even assuming the market risk here.

Best case scenario – 10% gain
Likely scenario – 3-4% gain
And worst case – 6-7% loss

Overall the risk reward are not too attractive, atleast to hold till the tender date.

However you can adopt an alternative approach – Hold your shares for some time and exit when the price approaches 900 levels. That way you will get a decent gain and not face the downside risk. I have to caution you that this would however be a speculative option.

Additional thoughts (not part of the above email)
ABB is currently selling at around 40+ times earnings. It may be undervalued, though I find that very hard to believe. If you share my opinion, then buying the stock at 820-830 levels with the ‘hope’ of selling at a higher price before the buyback would be a speculative position without a valuation support to it. As a result I have given this deal a pass.

Subscription

Enter your email address if you would like to be notified when a new post is posted:

I agree to be emailed to confirm my subscription to this list

Recent Posts

Select category to filter posts

Archives